170 related articles for article (PubMed ID: 2476531)
1. Long-term neurotoxicity in patients treated with cisplatin, vinblastine, and bleomycin for metastatic germ cell cancer.
Hansen SW; Helweg-Larsen S; Trojaborg W
J Clin Oncol; 1989 Oct; 7(10):1457-61. PubMed ID: 2476531
[TBL] [Abstract][Full Text] [Related]
2. Neuronal involvement in cisplatin neuropathy: prospective clinical and neurophysiological studies.
Krarup-Hansen A; Helweg-Larsen S; Schmalbruch H; Rørth M; Krarup C
Brain; 2007 Apr; 130(Pt 4):1076-88. PubMed ID: 17301082
[TBL] [Abstract][Full Text] [Related]
3. Late-effects after treatment for germ-cell cancer with cisplatin, vinblastine, and bleomycin.
Hansen SW
Dan Med Bull; 1992 Oct; 39(5):391-9. PubMed ID: 1385050
[TBL] [Abstract][Full Text] [Related]
4. Cisplatin neurotoxicity in the treatment of metastatic germ cell tumour: time course and prognosis.
von Schlippe M; Fowler CJ; Harland SJ
Br J Cancer; 2001 Sep; 85(6):823-6. PubMed ID: 11556831
[TBL] [Abstract][Full Text] [Related]
5. Lhermitte's sign as a complication of cisplatin-containing chemotherapy for testicular cancer.
Eeles R; Tait DM; Peckham MJ
Cancer Treat Rep; 1986 Jul; 70(7):905-7. PubMed ID: 2424594
[TBL] [Abstract][Full Text] [Related]
6. High-dose versus low-dose vinblastine in cisplatin-vinblastine-bleomycin combination chemotherapy of non-seminomatous testicular cancer: a randomized study of the EORTC Genitourinary Tract Cancer Cooperative Group.
Stoter G; Sleyfer DT; ten Bokkel Huinink WW; Kaye SB; Jones WG; van Oosterom AT; Vendrik CP; Spaander P; de Pauw M; Sylvester R
J Clin Oncol; 1986 Aug; 4(8):1199-206. PubMed ID: 2426419
[TBL] [Abstract][Full Text] [Related]
7. Vinblastine, cisplatin and bleomycin (VPB) adjuvant therapy does not induce dose-dependent damage in human chromosomes.
Gundy S; Baki M; Bodrogi I
Neoplasma; 1989; 36(4):457-64. PubMed ID: 2475796
[TBL] [Abstract][Full Text] [Related]
8. [Chemotherapeutic effectiveness in malignant testicular tumors at advanced stages. Preliminary results of the VAB VI program].
Chiricuţă I; Ghilezan N
Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1985; 34(6):455-68. PubMed ID: 2421373
[No Abstract] [Full Text] [Related]
9. Cancer of the testis: a new paradigm.
Einhorn LH
Hosp Pract (Off Ed); 1986 Apr; 21(4):165-72, 175-8. PubMed ID: 2420812
[No Abstract] [Full Text] [Related]
10. Transient left homonymous hemianopsia and encephalopathy following treatment of testicular carcinoma with cisplatinum, vinblastine, and bleomycin.
Cohen RJ; Cuneo RA; Cruciger MP; Jackman AE
J Clin Oncol; 1983 Jun; 1(6):392-3. PubMed ID: 6199475
[TBL] [Abstract][Full Text] [Related]
11. Combination cisplatin, vinblastine, and bleomycin chemotherapy (PVB) for malignant germ-cell tumors of the ovary.
Carlson RW; Sikic BI; Turbow MM; Ballon SC
J Clin Oncol; 1983 Oct; 1(10):645-51. PubMed ID: 6199468
[TBL] [Abstract][Full Text] [Related]
12. Long-term fertility and Leydig cell function in patients treated for germ cell cancer with cisplatin, vinblastine, and bleomycin versus surveillance.
Hansen SW; Berthelsen JG; von der Maase H
J Clin Oncol; 1990 Oct; 8(10):1695-8. PubMed ID: 1698935
[TBL] [Abstract][Full Text] [Related]
13. History of testicular cancer chemotherapy: maximizing efficacy, minimizing toxicity.
Sweeney C
Semin Urol Oncol; 2001 Aug; 19(3):170-9. PubMed ID: 11561984
[TBL] [Abstract][Full Text] [Related]
14. Reduced platelet survival following chemotherapy with vinblastine, bleomycin and cis-platinum for testicular teratoma.
Rees GJ; Slade RR; Hopes P
Eur J Cancer Clin Oncol; 1982 Nov; 18(11):1125-9. PubMed ID: 6186497
[TBL] [Abstract][Full Text] [Related]
15. Second malignancy after cisplatin, vinblastine, and bleomycin (PVB) chemotherapy: a case report.
Mead GM; Green JA; Macbeth FR; Williams CJ; Whitehouse JM; Buchanan R
Cancer Treat Rep; 1983 Apr; 67(4):410. PubMed ID: 6189603
[No Abstract] [Full Text] [Related]
16. Encephalopathy following cisplatin, bleomycin and vinblastine therapy for non-seminomatous germ cell tumour of testis.
Hitchins RN; Thomson DB
Aust N Z J Med; 1988 Feb; 18(1):67-8. PubMed ID: 2456056
[TBL] [Abstract][Full Text] [Related]
17. Hemorrhagic cystitis after i.v. bleomycin, vinblastine, cisplatin, and etoposide for testicular cancer.
Cantwell BM; Harris AL; Patrick D; Hall RR
Cancer Treat Rep; 1986 Apr; 70(4):548-9. PubMed ID: 2421895
[No Abstract] [Full Text] [Related]
18. Length of follow-up in teratomas--results of a modification of Einhorn's regime in testicular teratomas.
Wilkins M; Williams MV; Mort D; James KW; Webster DJ
Eur J Surg Oncol; 1986 Jun; 12(2):153-7. PubMed ID: 2423374
[TBL] [Abstract][Full Text] [Related]
19. A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumors.
Bosl GJ; Geller NL; Bajorin D; Leitner SP; Yagoda A; Golbey RB; Scher H; Vogelzang NJ; Auman J; Carey R
J Clin Oncol; 1988 Aug; 6(8):1231-8. PubMed ID: 2457657
[TBL] [Abstract][Full Text] [Related]
20. Examination of distal involvement in cisplatin-induced neuropathy in man. An electrophysiological and histological study with particular reference to touch receptor function.
Krarup-Hansen A; Fugleholm K; Helweg-Larsen S; Hauge EN; Schmalbruch H; Trojaborg W; Krarup C
Brain; 1993 Oct; 116 ( Pt 5)():1017-41. PubMed ID: 8221046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
